TOWARDS THE DEVELOPMENT OF IMPKOVED THROMBOLYTIC AGENTS
- 1 March 1991
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 77 (3) , 261-266
- https://doi.org/10.1111/j.1365-2141.1991.tb08568.x
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Construction and characterization of a recombinant murine monoclonal antibody directed against human fibrin fragment‐D dimerEuropean Journal of Biochemistry, 1990
- Biochemical properties of conjugates of urokinase‐type plasminogen activator with a monoclonal antibody specific for cross‐linked fibrinEuropean Journal of Biochemistry, 1989
- Serpin-resistant mutants of human tissue-type plasminogen activatorNature, 1989
- Conjugation to an antifibrin monoclonal antibody enhances the fibrinolytic potency of tissue plasminogen activator in vitroBiochemistry, 1988
- Comparative properties of two clinical preparations of recombinant human tissue-type plasminogen activator in patients with acute myocardial infarctionJournal of the American College of Cardiology, 1987
- Functional role of proteolytic cleavage at arginine-275 of human tissue plasminogen activator as assessed by site-directed mutagenesisBiochemistry, 1987
- Antibody-Directed Urokinase: A Specific Fibrinolytic AgentScience, 1985
- Evolution of the proteases of blood coagulation and fibrinolysis by assembly from modulesCell, 1985
- Common evolutionary origin of the fibrin‐binding structures of fibronectin and tissue‐type plasminogen activatorFEBS Letters, 1983
- Cloning and expression of human tissue-type plasminogen activator cDNA in E. coliNature, 1983